Such potential risks and uncertainties include, without limitation, the company's success in establishing federal partnerships that advance our Hemopurifier?? in the fields of biodefense, cancer, and chronic infectious diseases; the capability of the Hemopurifier?? to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer, including the ability to